PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Public Health England, London, UK jamie.lopezbernal2@phe.gov.uk.\', \'NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, UK.\', \'NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, London, UK.\', \'Public Health England, London, UK.\', \'University of Strathclyde, Glasgow, UK.\', \'Public Health Wales, Cardiff, UK.\', \'Public Health Agency Northern Ireland, Belfast, UK.\', \'Health Protection Scotland, Glasgow, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bmj.n1088
?:hasPublicationType
?:journal
  • BMJ (Clinical research ed.)
is ?:pmid of
?:pmid
?:pmid
  • 33985964
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all